Support teaching, research, and patient care.
Dr. Svensson is an Assistant Professor of Pathology in the School of Medicine at Stanford University and one of the Affinity Group Leaders of the Stanford Diabetes Research Center. She is also an Associate Editor at Endocrine Reviews. She received her Ph.D. from Lund University, Sweden and completed her postdoctoral studies with Bruce Spiegelman at Harvard Medical School and the Dana-Farber Cancer Institute, Boston. Her laboratory is dedicated to uncovering new signal transduction pathways and their therapeutic applications for metabolic disorders, including obesity, diabetes, and fatty liver disease. Her lab employs a combination of biochemistry, computational approaches, proteomics, and physiology to characterize hormones with previously unknown functions. Her lab has made several findings in their pursuit to improve metabolic health, including the discovery of Isthmin as a circulating hormone that regulates glucose and lipid homeostasis. Her laboratory is supported by grants from the NIH, American Heart Association, Innovative Medicines Accelerator, SPARK, and Merck.
The Svensson Laboratory is dedicated to the discovery of new ligands that can control metabolism. We are using a combination of omics, gene editing and physiology approaches to better understand how to target complex diseases such as aging, metabolic diseases, and cancer.